Johnson & Johnson's Sales Slump Has Played Itself Out, Could Reaccelerate This Year
May 15, 2017 at 11:10 AM EDT
JPMorgan's Michael Weinstein upgraded shares of Johnson & Johnson (NYSE: JNJ) from Neutral to Overweight with a price target boosted ...